Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
VQW-765 by Vanda Pharmaceuticals for Social Anxiety Disorder (SAD/Social Phobia): Likelihood of Approval
VQW-765 is under clinical development by Vanda Pharmaceuticals and currently in Phase II for Social Anxiety Disorder (SAD/Social Phobia). According...